Background
Methods
Patient identifier | Age | Sex | Tumor site | TNM stage | ΔtrpCT (days) | ΔtCBCT (days) | SIB prescription low dose/high dose (Gy) | Number of SIB fractions |
---|---|---|---|---|---|---|---|---|
Pat1 | 65 | M | Larynx | pT2pN0M0 | 51 | 50 | 50/- | 25 |
Pat2 | 54 | F | Hypopharynx, esophagus | cT4cN2M0 | 39 | 41 | 50.4/56 | 28 |
Pat3 | 71 | M | Larynx | pT1bN0M0 | 34 | 35 | 54/60 | 30 |
Pat4 | 87 | M | Hypopharynx | cT2cN2bM0 | 33 | 34 | 54/60 | 30 |
Pat5 | 49 | M | Nasopharynx | cT2cN2bM0 | 40 | 40 | 54/60 | 30 |
Pat6 | 42 | M | Larynx | pT2bpN1M0 | 44 | 41 | 50.4/56 | 28 |
Pat7 | 66 | M | Right paranasal sinus | pT2cN0M0 | 31 | 30 | 50.4/61.6 | 28 |
Pat8 | 67 | M | Left paranasal sinus | pT3N2bM0 | 30 | 30 | 54.4/64 | 32 |
Pat9 | 76 | M | Nasal cavity | cT3N0M0 | 37 | 38 | 50.4/56 | 28 |
Organ at risk or target | DVH parameters evaluated | DVH objectives used for planning |
---|---|---|
High dose PTV |
D
95, D
2
, V
95
|
V
95 = 100 %, D
min = 100 % · D
prescr., D
max < 105 % · D
prescr.
|
High dose CTV |
D
95, D
2
| |
Low dose PTV |
D
95, D
2
, V
95
|
V
95 = 100 %, D
min = 100 % · D
prescr., D
max < 105 % · D
prescr.
|
Low dose CTV |
D
95, D
2
| |
Parotid glands |
D
mean
|
D
mean < 26 Gy |
Spinal cord |
D
2
|
D
max < 53 Gy |
Brain stem |
D
2
|
D
max < 53 Gy |
Optical nerves |
D
2
|
D
max < 54 Gy |
Optical chiasm |
D
2
|
D
max < 56 Gy |
Eye |
D
2
|
D
max < 45 Gy |
Eye lens |
D
mean
|
D
mean < 10 Gy |